Clinical Trials Logo

Obsessive Thoughts clinical trials

View clinical trials related to Obsessive Thoughts.

Filter by:
  • None
  • Page 1

NCT ID: NCT05791578 Active, not recruiting - Obsessive Thoughts Clinical Trials

Relationship Obsessive Beliefs and Thought Control

Start date: December 1, 2022
Phase:
Study type: Observational [Patient Registry]

Obsessive beliefs and thought control have been mostly investigated in obsessive-compulsive disorder in the literature. However, there is an increasing body of literature indicating that obsessive beliefs and thought control also play a role in the development of other anxiety disorders. In the study, investigators hypothesised that obsessive beliefs and thought control are effective in generalised anxiety disorder and panic disorder and increase anxiety symptoms and aimed to investigate the accuracy of this hypothesis.

NCT ID: NCT04575805 Completed - Clinical trials for Obsessive-compulsive Disorders and Symptoms

Internet-delivered CBM-C for OC-symptoms

Start date: September 15, 2020
Phase: N/A
Study type: Interventional

A factorial randomised controlled trial comparing internet-delivered combined cognitive bias modification intervention (iCBM-C) versus internet-delivered CBM-interpretation intervention (iCBM-I), internet-delivered CBM-attention intervention (iCBM-A) and wait-list control on obsessive-compulsive (OC) symptoms, OC-beliefs, OC-related interpretation and attention biases

NCT ID: NCT03571464 Completed - Obsessive Thoughts Clinical Trials

Study of the Efficacy of GGRO: a Novel Cognitive Training App

GGRO
Start date: September 25, 2016
Phase: N/A
Study type: Interventional

The aim of the present study was to evaluate the efficacy of GGRO reducing OCD related maladaptive beliefs and OCD symptoms. Specifically, a randomized controlled trial with crossover design was carried out in non-clinical population to assess pre-post changes in levels of OCD-related maladaptive beliefs and OCD symptoms, including relationship OCD (ROCD) symptoms, self-esteem, and depressive symptoms following 15 days of using GGRO.